טוען...
Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
BACKGROUND: Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for various types of cancer. ICIs have revolutionized cancer treatment and improved clinical outcomes among cancer patients. However, immune-related adverse effects of ICI therapy are common. Cardiovascular immune-rela...
שמור ב:
| הוצא לאור ב: | World J Cardiol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7701899/ https://ncbi.nlm.nih.gov/pubmed/33312443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v12.i11.584 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|